Literature DB >> 20383548

Psychometric evaluation of the Moroccan version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) for use in patients with ankylosing spondylitis.

Samira Rostom1, Karima Benbouaaza, Bouchra Amine, Rachid Bahiri, Yousra Ibn Yacoub, Sanae Ali Ou Alla, Redouane Abouqal, Najia Hajjaj-Hassouni.   

Abstract

The objectives of this study are to translate, adapt in the Moroccan cultural context, and validate in patients with ankylosing spondylitis (AS) the Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI). The cross-cultural adaptation of the BASFI and BASDAI was obtained in accordance with the guidelines for translation of the health status measures. Eighty-five patients with AS were included in the study. The test-retest reliability and the internal consistency were analyzed, and both questionnaires were assessed for external construct validity. Structural validity was analyzed with correlation matrix. Twenty-four-hour test-retest reliability was good: BASFI intraclass correlation coefficient (ICC) = 0.96 (confidence interval (CI) at 95%, 0.93-0.97), BASDAI ICC = 0.93 (CI at 95%, 0.90-0.95). Cronbach's alpha was 0.90 for the BASFI and 0.86 for BASDAI. The construct validity of the instruments was evaluated. The BASFI showed a strong validity when correlating its results with Schober's test (r = -0.56), occipital wall distance (r = 0.46), chest expansion (r = -0.46), BASDAI (r = 0.54), Bath Ankylosing Spondylitis Metrology Index (r = 0.70), Bath Ankylosing Spondylitis Global Score (BAS-G; r = 0.58), Bath Ankylosing Spondylitis Radiology Index (r = 0.61), and the radiological changes in sacroiliac joints (r = 0.54). A good correlation was observed between the BASDAI and the spinal pain (r = 0.53), the number of nocturnal awakenings (r = 0.57), the morning stiffness (r = 0.65), the enthesic index (r = 0.47), the BAS-G (r = 0.53), the BASFI (r = 0.54), and the erythrocyte sedimentation rate (r = 0.41; for all p < 0.001). The correlation matrix showed an intermediate correlation between items. The Moroccan version of the BASFI and the BASDAI showed adequate reliability and validity. These instruments can be used in the clinical evaluation of Moroccan and Arabic-speaking patients with AS.

Entities:  

Mesh:

Year:  2010        PMID: 20383548     DOI: 10.1007/s10067-010-1431-5

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  23 in total

1.  The Swedish version of the Bath ankylosing spondylitis functional index. Reliability and validity.

Authors:  H Cronstedt; A Waldner; C H Stenström
Journal:  Scand J Rheumatol Suppl       Date:  1999

2.  The Bath Ankylosing Spondylitis Patient Global Score (BAS-G).

Authors:  S D Jones; A Steiner; S L Garrett; A Calin
Journal:  Br J Rheumatol       Date:  1996-01

3.  Cross-cultural adaptation and validation of health status measures.

Authors:  F Guillemin
Journal:  Scand J Rheumatol       Date:  1995       Impact factor: 3.641

Review 4.  Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines.

Authors:  F Guillemin; C Bombardier; D Beaton
Journal:  J Clin Epidemiol       Date:  1993-12       Impact factor: 6.437

5.  Evaluation of the Finnish versions of the functional indices BASFI and DFI in spondylarthropathy.

Authors:  S Heikkilä; J V Viitanen; H Kautianen; M Kauppi
Journal:  Clin Rheumatol       Date:  2000       Impact factor: 2.980

6.  The Turkish versions of the Bath Ankylosing Spondylitis and Dougados Functional Indices: reliability and validity.

Authors:  Altinay Goksel Karatepe; Yesim Akkoc; Servet Akar; Yesim Kirazli; Nurullah Akkoc
Journal:  Rheumatol Int       Date:  2004-07-10       Impact factor: 2.631

7.  A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.

Authors:  A Calin; S Garrett; H Whitelock; L G Kennedy; J O'Hea; P Mallorie; T Jenkinson
Journal:  J Rheumatol       Date:  1994-12       Impact factor: 4.666

8.  A Turkish version of the Bath Ankylosing Spondylitis Disease Activity Index: reliability and validity.

Authors:  Yesim Akkoc; Altinay Goksel Karatepe; Servet Akar; Yesim Kirazli; Nurullah Akkoc
Journal:  Rheumatol Int       Date:  2004-01-17       Impact factor: 2.631

9.  The Bath Ankylosing Spondylitis Radiology Index (BASRI): a new, validated approach to disease assessment.

Authors:  K MacKay; C Mack; S Brophy; A Calin
Journal:  Arthritis Rheum       Date:  1998-12

10.  Translation, cross-cultural adaptation, and validation of the Bath Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and the Dougados Functional Index (DFI) in a Spanish speaking population with spondyloarthropathies.

Authors:  M H Cardiel; J D Londoño; E Gutiérrez; C Pacheco-Tena; J Vázquez-Mellado; R Burgos-Vargas
Journal:  Clin Exp Rheumatol       Date:  2003 Jul-Aug       Impact factor: 4.473

View more
  16 in total

1.  Fatigue in patients with ankylosing spondylitis: prevalence and relationships with disease-specific variables, psychological status, and sleep disturbance.

Authors:  N Aissaoui; S Rostom; J Hakkou; K Berrada Ghziouel; R Bahiri; R Abouqal; N Hajjaj-Hassouni
Journal:  Rheumatol Int       Date:  2011-04-24       Impact factor: 2.631

2.  Health-related quality of life in Moroccan patients with ankylosing spondylitis.

Authors:  Yousra Ibn Yacoub; Bouchra Amine; Assia Laatiris; Redouane Abouqal; Najia Hajjaj-Hassouni
Journal:  Clin Rheumatol       Date:  2010-10-31       Impact factor: 2.980

3.  Sleep disturbance in Moroccan patients with ankylosing spondylitis: prevalence and relationships with disease-specific variables, psychological status and quality of life.

Authors:  Jinane Hakkou; Samira Rostom; Mariam Mengat; Nawal Aissaoui; Rachid Bahiri; Najia Hajjaj-Hassouni
Journal:  Rheumatol Int       Date:  2012-03-24       Impact factor: 2.631

4.  Comparison of the BASDAI and the miniBASDAI in assessing disease activity in patients with ankylosing spondylitis.

Authors:  Jinane Hakkou; Samira Rostom; Nawal Aissaoui; Kenza Berrada Ghezioul; Rachid Bahiri; Redouane Abouqal; Najia Hajjaj-Hassouni
Journal:  Clin Rheumatol       Date:  2011-10-12       Impact factor: 2.980

5.  Spinal mobility and its impact in Moroccan patients with ankylosing spondylitis.

Authors:  Yousra Ibn Yacoub; Bouchra Amine; Assia Laatiris; Redouane Abouqal; Najia Hajjaj-Hassouni
Journal:  Clin Rheumatol       Date:  2010-11-06       Impact factor: 2.980

6.  Psychometric evaluation of the Arabic version of the multidimensional assessment of fatigue scale (MAF) for use in patients with ankylosing spondylitis.

Authors:  Hanane Bahouq; Samira Rostom; Rachid Bahiri; Jinane Hakkou; Nawal Aissaoui; Najia Hajjaj-Hassouni
Journal:  Rheumatol Int       Date:  2011-12-29       Impact factor: 2.631

7.  Evaluation of the Iranian versions of the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), the Bath Ankylosing Spondylitis Functional Index (BASFI) and the Patient Acceptable Symptom State (PASS) in patients with ankylosing spondylitis.

Authors:  Katayoon Bidad; Sasan Fallahi; Mahdi Mahmoudi; Ahmadreza Jamshidi; Elham Farhadi; Alipasha Meysamie; Mohammad Hossein Nicknam
Journal:  Rheumatol Int       Date:  2011-11-20       Impact factor: 2.631

8.  Enthesitis and its relationships with disease parameters in Moroccan patients with ankylosing spondylitis.

Authors:  Assia Laatiris; Bouchra Amine; Yousra Ibn Yacoub; Najia Hajjaj-Hassouni
Journal:  Rheumatol Int       Date:  2010-12-15       Impact factor: 2.631

9.  Functional limitations due to axial and peripheral joint impairments in patients with ankylosing spondylitis: are focused measures more informative?

Authors:  Siddharth Bethi; Abhijit Dasgupta; Michael H Weisman; Thomas J Learch; Lianne S Gensler; John C Davis; John D Reveille; Michael M Ward
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-04       Impact factor: 4.794

10.  Early diagnosis and treatment of ankylosing spondylitis in Africa and the Middle East.

Authors:  Bahiri Rachid; Bassel El Zorkany; Ehab Youseif; Mohammed Tikly
Journal:  Clin Rheumatol       Date:  2012-08-19       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.